相似文献
1
Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain.
J Clin Microbiol. 2013 Jun;51(6):1927-30. doi: 10.1128/JCM.00494-13. Epub 2013 Mar 27.
2
Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
J Cyst Fibros. 2016 Jul;15(4):486-94. doi: 10.1016/j.jcf.2015.12.009. Epub 2016 Jan 8.
3
Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.
Front Cell Infect Microbiol. 2017 May 29;7:224. doi: 10.3389/fcimb.2017.00224. eCollection 2017.
4
Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.
J Clin Microbiol. 2012 Aug;50(8):2688-94. doi: 10.1128/JCM.00728-12. Epub 2012 Jun 6.
5
Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
J Clin Microbiol. 2015 Dec;53(12):3894-6. doi: 10.1128/JCM.02197-15.
6
Identification and distribution of Achromobacter species in cystic fibrosis.
J Cyst Fibros. 2013 May;12(3):298-301. doi: 10.1016/j.jcf.2012.10.002. Epub 2012 Nov 7.
7
Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis.
Epidemiol Infect. 2017 Feb;145(3):600-606. doi: 10.1017/S0950268816002624. Epub 2016 Nov 22.
8
A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species.
J Clin Microbiol. 2012 Sep;50(9):3010-5. doi: 10.1128/JCM.00814-12. Epub 2012 Jul 11.
9
Genomic characterization of species isolates from chronic and occasional lung infection in cystic fibrosis patients.
Microb Genom. 2021 Jul;7(7). doi: 10.1099/mgen.0.000606.
10
Prevalence and species distribution of Achromobacter sp. cultured from cystic fibrosis patients attending the Aarhus centre in Denmark.
J Med Microbiol. 2017 May;66(5):686-689. doi: 10.1099/jmm.0.000499. Epub 2017 May 8.
引用本文的文献
1
Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains.
Ann Clin Microbiol Antimicrob. 2024 Jun 17;23(1):54. doi: 10.1186/s12941-024-00709-z.
2
Susceptibility of Species Isolated from Cystic Fibrosis Patients: a 6-Year Survey.
Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0037923. doi: 10.1128/aac.00379-23. Epub 2023 Jun 13.
3
Inhaled Bacteriophage Therapy for Multi-Drug Resistant .
Yale J Biol Med. 2022 Dec 22;95(4):413-427. eCollection 2022 Dec.
4
Characterization of the Type VI Secretion System and Its Implication in Cystic Fibrosis.
Front Cell Infect Microbiol. 2022 Jun 16;12:859181. doi: 10.3389/fcimb.2022.859181. eCollection 2022.
5
Distribution of Species in 12 French Cystic Fibrosis Centers in 2020 by a Retrospective MALDI-TOF MS Spectrum Analysis.
J Clin Microbiol. 2022 Jun 15;60(6):e0242221. doi: 10.1128/jcm.02422-21. Epub 2022 May 5.
6
Adaptive Interactions of spp. with in Cystic Fibrosis Chronic Lung Co-Infection.
Pathogens. 2021 Aug 3;10(8):978. doi: 10.3390/pathogens10080978.
7
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Rapid Detection of Isolates Belonging to the Epidemic Clones Achromobacter xylosoxidans ST137 and Achromobacter ruhlandii DES from Cystic Fibrosis Patients.
J Clin Microbiol. 2021 Sep 20;59(10):e0094621. doi: 10.1128/JCM.00946-21. Epub 2021 Aug 4.
8
Genomic characterization of species isolates from chronic and occasional lung infection in cystic fibrosis patients.
Microb Genom. 2021 Jul;7(7). doi: 10.1099/mgen.0.000606.
9
Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis.
mBio. 2021 Mar 9;12(2):e02863-20. doi: 10.1128/mBio.02863-20.
10
Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Species from Cystic Fibrosis Patients.
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.01467-20.
本文引用的文献
1
Achromobacter animicus sp. nov., Achromobacter mucicolens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples.
Syst Appl Microbiol. 2013 Feb;36(1):1-10. doi: 10.1016/j.syapm.2012.10.003. Epub 2012 Dec 6.
2
Identification and distribution of Achromobacter species in cystic fibrosis.
J Cyst Fibros. 2013 May;12(3):298-301. doi: 10.1016/j.jcf.2012.10.002. Epub 2012 Nov 7.
3
Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump.
Antimicrob Agents Chemother. 2013 Jan;57(1):603-5. doi: 10.1128/AAC.01243-12. Epub 2012 Oct 22.
4
A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species.
J Clin Microbiol. 2012 Sep;50(9):3010-5. doi: 10.1128/JCM.00814-12. Epub 2012 Jul 11.
5
Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.
J Clin Microbiol. 2012 Aug;50(8):2688-94. doi: 10.1128/JCM.00728-12. Epub 2012 Jun 6.
6
Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients.
J Clin Microbiol. 2011 Oct;49(10):3649-51. doi: 10.1128/JCM.05283-11. Epub 2011 Aug 17.
7
Identification of Achromobacter xylosoxidans by detection of the bla(OXA-114-like) gene intrinsic in this species.
Diagn Microbiol Infect Dis. 2011 Jul;70(3):408-11. doi: 10.1016/j.diagmicrobio.2011.02.007. Epub 2011 Apr 15.
8
Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.
Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):973-80. doi: 10.1007/s10096-011-1182-5. Epub 2011 Jan 31.
9
The changing microbial epidemiology in cystic fibrosis.
Clin Microbiol Rev. 2010 Apr;23(2):299-323. doi: 10.1128/CMR.00068-09.
10
Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
J Cyst Fibros. 2010 Jan;9(1):51-8. doi: 10.1016/j.jcf.2009.10.005. Epub 2009 Nov 25.
Zotero 插件